Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||
net income | -19,726,000 | -30,322,000 | -35,996,000 | -65,714,000 | 37,037,000 | -4,407,000 | -62,412,000 | -54,511,000 | -46,150,000 | -45,863,000 | -42,393,000 | -40,109,000 | -37,795,000 | -36,530,000 | -27,747,000 | -21,938,000 | -19,241,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||
acquired in-process research and development assets | 0 | 0 | 0 | 0 | |||||||||||||
share-based compensation expense | 9,561,000 | 10,898,000 | 12,861,000 | 11,035,000 | 11,554,000 | 13,030,000 | 12,644,000 | 10,811,000 | 9,606,000 | 9,477,000 | 9,447,000 | 6,833,000 | 8,576,000 | 5,631,000 | 6,202,000 | 5,097,000 | 5,149,000 |
depreciation expense | 90,000 | 91,000 | 94,000 | 38,000 | 16,000 | 15,000 | 23,000 | 13,000 | 11,000 | 6,000 | 6,000 | 15,000 | 36,000 | 6,000 | 6,000 | ||
accretion of discounts on short-term investments | -4,121,000 | -4,152,000 | -4,250,000 | -2,823,000 | -1,377,000 | -897,000 | -1,292,000 | -1,576,000 | -2,644,000 | -5,259,000 | -599,000 | -999,000 | |||||
amortization of intangible assets | 795,000 | 795,000 | 725,000 | 586,000 | 586,000 | ||||||||||||
amortization of operating right-of-use asset | 49,000 | 78,000 | 75,000 | 135,000 | 144,000 | ||||||||||||
income from sale of property and equipment | 0 | ||||||||||||||||
gain from sale of priority review voucher | 0 | 0 | |||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||
accounts receivable | 2,972,000 | -1,615,000 | -4,178,000 | -5,181,000 | 441,000 | ||||||||||||
inventory | -480,000 | -2,940,000 | -212,000 | -560,000 | -2,554,000 | ||||||||||||
prepaid expenses and other current assets | 480,000 | -1,101,000 | -606,000 | -2,230,000 | 752,000 | -3,915,000 | 837,000 | -1,174,000 | -851,000 | -2,693,000 | 1,396,000 | 567,000 | 1,467,000 | -3,002,000 | 422,000 | 1,091,000 | -86,000 |
deposits and other long-term assets | -134,000 | 32,000 | -94,000 | -4,000 | 0 | 50,000 | 47,000 | 19,000 | 26,000 | 228,000 | -18,000 | -20,000 | 35,000 | -319,000 | 4,000 | -31,000 | -12,000 |
accounts payable | 688,000 | 2,550,000 | -722,000 | 245,000 | -3,427,000 | 1,664,000 | 2,204,000 | -815,000 | -1,174,000 | -74,000 | 4,379,000 | -3,713,000 | 3,534,000 | -262,000 | -1,043,000 | 1,059,000 | 338,000 |
accrued expenses and other current liabilities | 4,079,000 | 490,000 | -26,984,000 | 33,436,000 | -51,883,000 | 62,313,000 | -1,765,000 | 5,877,000 | 1,128,000 | 1,759,000 | 1,810,000 | 2,114,000 | 1,903,000 | 4,629,000 | 595,000 | 1,549,000 | 1,628,000 |
deferred revenue | 52,000 | 232,000 | 199,000 | 264,000 | |||||||||||||
operating lease liability | -110,000 | 87,000 | 91,000 | 4,000 | -59,000 | ||||||||||||
net cash from operating activities | -5,805,000 | -24,806,000 | -58,997,000 | -30,008,000 | 50,753,000 | -49,129,000 | -49,729,000 | -41,372,000 | -37,064,000 | -42,432,000 | -25,985,000 | -35,310,000 | -23,214,000 | -29,787,000 | -21,563,000 | -13,169,000 | -12,221,000 |
capex | 0 | -3,000 | -317,000 | -1,419,000 | -724,000 | 0 | 0 | -8,000 | -41,000 | -149,000 | 6,000 | 0 | 0 | 0 | 0 | 0 | 0 |
free cash flows | -5,805,000 | -24,809,000 | -59,314,000 | -31,427,000 | 50,029,000 | -49,129,000 | -49,729,000 | -41,380,000 | -37,105,000 | -42,581,000 | -25,979,000 | -35,310,000 | -23,214,000 | -29,787,000 | -21,563,000 | -13,169,000 | -12,221,000 |
cash flows from investing activities: | |||||||||||||||||
cash paid for purchase of short-term investments | -209,565,000 | -238,502,000 | -189,796,000 | -275,221,000 | -214,634,000 | -121,599,000 | -47,162,000 | -99,137,000 | -79,957,000 | -104,730,000 | -160,014,000 | -121,368,000 | -266,848,000 | ||||
proceeds from maturity of short-term investments | 223,025,000 | 264,795,000 | 161,000,000 | 7,000,000 | 123,250,000 | 47,782,000 | 136,450,000 | 171,915,000 | 125,153,000 | 148,847,000 | |||||||
proceeds from sale of short-term investments | 0 | ||||||||||||||||
cash paid for acquired intangible assets | 0 | 0 | -3,500,000 | 0 | 0 | ||||||||||||
proceeds from sale of priority review voucher | 0 | 0 | |||||||||||||||
cash paid for acquired in-process research and development assets | 0 | 0 | 0 | 0 | |||||||||||||
cash paid for purchase of property and equipment | 0 | -3,000 | -317,000 | -1,419,000 | -724,000 | -8,000 | -41,000 | -149,000 | -26,000 | 0 | |||||||
proceeds from sale of property and equipment | 0 | ||||||||||||||||
net cash from investing activities | 13,460,000 | 26,322,000 | -32,613,000 | -269,640,000 | -67,699,000 | 17,057,000 | 89,288,000 | 88,917,000 | 20,274,000 | -11,193,000 | -2,210,000 | ||||||
cash flows from financing activities: | |||||||||||||||||
proceeds from issuance of common stock in connection with private placement, net of placement agent fees and offering costs | 0 | ||||||||||||||||
proceeds from issuance of prefunded warrants to purchase common stock in connection with private placement, net of issuance costs | 0 | ||||||||||||||||
proceeds from issuance of common stock upon stock option exercises | 918,000 | 977,000 | 324,000 | 48,000 | 0 | 115,000 | 39,000 | 1,184,000 | 1,596,000 | ||||||||
proceeds from issuance of common stock upon employee stock purchase plan purchase | 0 | 933,000 | 0 | 0 | |||||||||||||
cash from financing activities | 0 | 1,851,000 | 200,095,000 | 1,297,000 | 48,000 | 115,000 | 162,101,000 | 1,184,000 | |||||||||
net increase in cash and cash equivalents | 7,655,000 | 2,264,000 | -91,610,000 | -297,797,000 | 183,149,000 | -30,775,000 | 39,607,000 | -10,395,000 | 51,968,000 | -35,602,000 | -268,013,000 | 126,146,000 | -21,578,000 | -12,851,000 | -12,836,000 | ||
cash and cash equivalents, beginning of period | 0 | 0 | 124,968,000 | 0 | 0 | 0 | 230,784,000 | 0 | 0 | 0 | 85,262,000 | 0 | 0 | 0 | 284,309,000 | 0 | 0 |
cash and cash equivalents, end of period | 7,655,000 | 2,264,000 | 33,358,000 | -297,797,000 | 183,149,000 | -30,775,000 | 270,391,000 | -10,395,000 | 51,968,000 | 139,943,000 | 49,268,000 | -35,602,000 | -268,013,000 | 126,146,000 | 262,731,000 | -12,851,000 | -12,836,000 |
supplemental disclosure of cash flow information: | |||||||||||||||||
income taxes paid | 0 | 1,015,000 | |||||||||||||||
supplemental disclosures of noncash activities: | |||||||||||||||||
cash not yet paid for acquired intangible asset | 0 | 0 | 2,000,000 | ||||||||||||||
right-of-use asset obtained in exchange for new operating lease liabilities | 0 | 0 | 230,000 | 0 | |||||||||||||
deferred offering costs not yet paid | |||||||||||||||||
cash not yet paid for upfront license agreement payment | |||||||||||||||||
other long-term liability | |||||||||||||||||
proceeds from issuance of common stock | 0 | 0 | 0 | 0 | 0 | -615,000 | |||||||||||
cash not yet paid for license agreement milestone payment | |||||||||||||||||
purchases of property and equipment included in accrued expenses and other current liabilities | |||||||||||||||||
unpaid/deferred offering costs | |||||||||||||||||
amortization of operating right-of-use assets | 93,000 | 90,000 | 88,000 | 86,000 | 83,000 | 165,000 | 129,000 | 127,000 | 47,000 | 46,000 | 45,000 | ||||||
operating lease liabilities | -108,000 | -106,000 | -104,000 | -99,000 | -96,000 | -163,000 | -68,000 | -67,000 | -49,000 | -28,000 | -52,000 | ||||||
cash flows from operating activities | |||||||||||||||||
cash flows from investing activities | |||||||||||||||||
proceeds from maturity of short-term investment | |||||||||||||||||
net cash from (used) in investing activities | |||||||||||||||||
cash flows from financing activities | |||||||||||||||||
proceeds from issuance of series b redeemable convertible preferred shares, net of issuance costs | 0 | 0 | |||||||||||||||
proceeds from issuance of common stock upon espp purchase | 322,000 | 0 | |||||||||||||||
net cash from financing activities | 318,000 | -615,000 | |||||||||||||||
supplemental disclosures of noncash activities | |||||||||||||||||
lease liability obtained in exchange for right-of-use asset | 0 | 0 | |||||||||||||||
exchange of 45,331,483 preferred, common, and incentive shares in connection with the conversion | 0 | 0 | |||||||||||||||
exchange of redeemable convertible noncontrolling interest to 6,470,382 shares of common stock | 0 | 0 | |||||||||||||||
net decrease in cash and cash equivalents | -35,994,000 | ||||||||||||||||
purchases of property and equipment included in accounts payable and in accrued expenses and other current liabilities | 32,000 | ||||||||||||||||
non-cash interest expense | 5,000 | ||||||||||||||||
changes in derivative tranche liabilities | |||||||||||||||||
proceeds from issuance of series a redeemable convertible preferred shares, net of issuance costs | |||||||||||||||||
transfers to redeemable convertible noncontrolling interest | |||||||||||||||||
cash paid for property and equipment | |||||||||||||||||
cash from investing activities | -5,997,000 | -15,000 | 0 | 0 | |||||||||||||
property and equipment expenditures | -15,000 | ||||||||||||||||
payments of financing issuance costs | |||||||||||||||||
depreciation and amortization expense | 5,000 | 5,000 | |||||||||||||||
issuance of shares for research and development | |||||||||||||||||
purchases of property and equipment | |||||||||||||||||
proceeds from issuance of convertible notes | |||||||||||||||||
recognition of contingent beneficial conversion feature upon notes conversion | |||||||||||||||||
issuance of series a redeemable convertible shares for research and development | |||||||||||||||||
conversion of convertible notes and accrued interest into series a redeemable convertible preferred shares | |||||||||||||||||
issuance of derivative tranches liability | |||||||||||||||||
right of use asset capitalization | |||||||||||||||||
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
